Sean McClain, AbSci
Months after striking a deal with Sanofi, AbSci nails its largest fundraise yet to support its protein printing tech
Months after nailing down a $10.4 million Series D and a partnership with French pharma giant Sanofi, AbSci is pulling in its largest fundraise yet …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
